Back to Journals » Drug Design, Development and Therapy » Volume 5

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Total article views   HTML views PDF downloads Totals
43,757 Dovepress* 21,136+ 3,685 24,821
PubMed Central* 22,621 3,798 26,419
Totals 43,757 7,483 51,240
*Since 10 March 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 1 7

View citations on PubMed Central and Google Scholar